Clinical Trial Update: Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating haplo-identical viral-specific T cells to treat cytomegalovirus and adenovirus infections after hematopoietic cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection

Drugs mentioned

• Haplo-identical viral-specific T-cells

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Cytomegalovirus, Adenovirus | Phase 2 | Status: RECRUITING